Innovations in device-based interventions, gene therapy, and precision pharmacology are driving growth in the refractory epilepsy treatment market by improving seizure control for patients unresponsive to traditional therapies. https://www.datamintelligence.com/research-report/refractory-epilepsy-treatment-market